Listen to the Latest Scientific Audiobook Releases

Delve deeper into the critical processes behind early phase drug development with audio versions of eBooks and The Altascientist, written by our experts with you in mind:

The Altascientist: Issue 30 — The Evolution and Advancement of LCMS in Drug Development Learn how the latest LC-MS advancements ensure accurate and precise data delivery in your drug development program. Listen to the audiobook >>>	The Altascientist: Issue 28 — Applications of Liquid-Filled, Hard-Shell Capsules in Drug Development Discover the advantages that liquid-filled, hard-shell capsules offer for the formulation of highly potent APIs and drugs that benefit from slow or extended release. Listen to the audiobook >>>
The Altascientist: Issue 29 — Building Your Early Phase Clinical Trial Data, From Protocol to Regulatory Submission Explore best practices and approaches for mitigating challenges when it comes to your data and bringing your drug to market. Listen to the audiobook >>>	eBook: First-in-Human Solution for Small and Large Molecules Uncover Altasciences' comprehensive, multi-service solution for your first-in-human trials—beyond the clinic. Listen to the audiobook >>>

DON'T JUST TAKE OUR WORD FOR IT...

Altasciences has leading expertise in the formulation and manufacturing of highly potent APIs and controlled substances, which often present unique complexities.

When Emyria presented us with the challenge of creating a cannabidiol (CBD) formulation from scratch for a new over-the-counter product in a very short time period, they trusted that we had the skills to successfully deliver.

Here’s what Emyria had to say about why they chose Altasciences and their experience:

"As a young company new to drug development, we chose to work with Altasciences because of their experience and reputation for excellence.

Altasciences has been a great partner for us in the early drug development phase; they helped us navigate the difficult path from formulation through to clinical manufacturing. In one short year, we have gone from idea through to Phase III clinical trials. They operate in a fully qualified, FDA-inspected cGMP facility. Their team meets with us weekly to keep us informed, and is always approachable and available for questions, comments, or concerns. They have shown a high degree of patience and flexibility with our changing needs.

We enjoy working with the team at Altasciences and wouldn't hesitate to recommend them."

Speak with one of our experts today for all your drug development needs― from early prototype formulation, to preclinical testing and clinical trial supply, all the way through to commercial manufacturing.

Related Resources:

• Case Study: Rapid Development of a Liquid-filled, Hard-Shell Capsule Formulation of Cannabidiol
• Webpage: Contract Manufacturing and Analytical Solutions
• Webpage: Customer Testimonials

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

The process from lead molecule identification to completion of a first‑in‑human trial can be long and complicated. But with Altasciences’ Proactive Drug Development solution, your timelines can be reduced by up to 40%. Your entire program will be managed by one organization and overseen by a single, cross-functional program manager to quickly and seamlessly advance your molecule from preclinical testing to first‑in‑human clinical trials, and beyond—helping you get your medicines to the people who need them, faster.

Learn more by downloading our eBook.

Altasciences keeps you on track, milestone to milestone.

Avoid delays caused by operational roadblocks, miscommunications, and lack of data sharing. 

Discover a simpler way to drug development success and how Altasciences’ integrated end-to-end CRO/CDMO solutions can safely move your molecule seamlessly from one phase to the next, and to market faster.

Start Watching!

Got 5 more minutes? Check out: 

• Webpage: Our Full Array of Drug Development, Manufacturing, and Analytical Solutions
• Scientific Paper: Benefits of Liquid-Filled Capsules Versus Tablets in Pharmaceutical Development

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

Biomarkers Inform the Drug Development Process for Large and Small Molecule Drugs

Altasciences can extract meaningful data from measuring various intracellular, membrane-bound, and secreted circulating biomarkers to inform the development process.

We will help guide you towards a robust and fit-for-purpose biomarker solution involving veteran scientists, toxicologists and clinical pharmacologists to develop a comprehensive preclinical to clinical plan to maximize the translation of results from one phase to the next. 

Let’s get started!

You may also be interested in the following:

• Biomarkers and Biosimilars list
• Bioanalytical Services
• Comprehensive Research Support Services

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

One-Stop Solution for Meeting Your Needs in Outsourcing Drug Development

Altasciences recently conducted a survey to understand the challenges biopharmaceutical companies face when outsourcing their early phase drug development programs. Over 143 executives shared the important factors that guide them in the selection of a CRO partner.

Their candid testimonials are shared in this playbook, including:

• The significant challenges encountered when conducting preclinical and Phase I studies
• The unique difficulties of transitioning from preclinical to first-in-human studies 
• The specific capabilities and expertise executives look for in their CRO partners
• The novel drug development solution approach for addressing the challenges encountered

Download your copy today.

Let us help!  Speak with our experts today.

You may also be interested in the following:

Webpages:

• Proactive Drug Development
• Early Phase Drug Development Solutions

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

Moving in Unison to Bring Your Vision to Life 

Trust is an important factor in any relationship. And we know trust is earned. 

That’s why at Altasciences, our focus is on you. We build strong relationships with each client through quality science and  proactive, responsive, and transparent communication that ensures you only have to Tell Us Once™. 

When you choose us, you are choosing a partner that will work as an extension of your team — who treats you like colleagues and your projects as our own. We’ll work side by side, getting to know your goals and understanding your needs. From preclinical to clinical proof of concept, and beyond, we’ll advance your molecule in one integrated, seamless process, celebrating your milestones together. 

Why? Because drug development isn’t a transaction — it’s a journey. Speak with an Altasciences expert to start your journey.
 

Watch this video to discover what it means to partner with Altasciences:

Have five minutes? Take a look at these: 

• Check out our new interactive brochure
• Discover our Proactive Drug Development solution
• Read this blog article: Moving Your Drug Forward to Preclinical Trials
• Explore our customizable and flexible early phase solution offering
• Read this Q&A featuring Marie-Hélène Raigneau, our Co-Chief Operating Officer​​​​​

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.